Advertisement
U.S. markets open in 7 hours 7 minutes

Nyxoah S.A. (NYXH)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
15.25-0.48 (-3.02%)
At close: 03:59PM EST
15.38 +0.13 (+0.85%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close15.73
Open14.89
Bid0.00 x 800
Ask0.00 x 1200
Day's Range13.86 - 15.35
52 Week Range4.00 - 15.89
Volume61,592
Avg. Volume43,869
Market Cap437.278M
Beta (5Y Monthly)0.44
PE Ratio (TTM)N/A
EPS (TTM)-1.81
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.26
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NYXH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Nyxoah SA
    Daily – Vickers Top Buyers & Sellers for 12/04/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • GlobeNewswire

    Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

    Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 Mont-Saint-Guibert, Belgium – February 15, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the fourth quarter and financial year 2023 on Tuesd

  • GlobeNewswire

    Nyxoah Announces 2024 Strategic Priorities

    Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced, in anticipation of upcoming investor meetings, its strategic priorities for 2024. 2024 Strategic Priorities Complete patient follow up in the DREAM U.S.

  • GlobeNewswire

    Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023

    Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023 Mont-Saint-Guibert, Belgium – January 9, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced certain preliminary, unaudited results for the fourth quarter and full year ended December 31, 2023. Preliminary, Unau